Rhumbline Advisers Genfit S.A. Put Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
7Shares Held
205KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny166KShares$648,8620.0% of portfolio
-
Morgan Stanley New York, NY34.7KShares$135,4080.0% of portfolio
-
Ubs Group Ag3.05KShares$11,8870.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7266Shares$1,0370.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ250Shares$9750.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $194M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...